BioPharma Dive October 22, 2024
Elise Reuter

Michelle Tarver will officially replace longtime CDRH leader Jeff Shuren, who stepped down from the role earlier this year.

The Food and Drug Administration on Tuesday named Michelle Tarver as the permanent director of the agency’s device center.

Tarver was appointed as acting director of the Center for Devices and Radiological Health in July, when longtime leader Jeff Shuren stepped down.

FDA Commissioner Robert Califf emphasized Tarver’s “passion about data, science, medicine, and the evidence” and work to build collaboration and transparency at the agency, in an email to staff announcing the new director’s appointment seen by MedTech Dive.

“As someone who has served the FDA for more than 15 years, I am immensely proud of the work we have...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Medical Devices
The FDA Should Reduce Nicotine In Cigarettes—And Use A Better Test To Ensure It Happens
FDA Approves Sixth Ustekinumab Biosimilar, Yesintek
Trump's health team: RFK Jr. and 5 doctors tapped to lead 'MAHA'
Healthy Returns: Trump’s FDA pick Makary may be a relief for biotech and pharma, analysts say
The telehealth background of Trump's FDA pick: 6 notes

Share This Article